BioNexus Gene Lab

BGLC

NASDAQIndustrials

Income Statement

Total Revenue$9.51M

Gross Profit$1.29M

Operating Income$-3.65M

EBITDA$-1.42M

EBIT$-1.57M

Pre-tax Income$-2.37M

Net Income$-1.6M

Net Cash$11.53M

Cash Equivalent$2.08M

Total Debt$271.45K

Net Debt$-11.26M

Book Value$9.15M

Net Cash Per Share6.42

Book Value Per Share5.14

Return on Equity (ROE)-19.20%

Return on Assets (ROA)-15.32%

Return on Invested Capital (ROI)-19.20%

Net Profit Margin-16.81%

Current Ratio3.81

Quick Ratio3.10

Long-Term Debt / Equitynull